BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Prognosis
22 results:

  • 1. Pan-cancer analysis of the tumorigenic role of Fanconi anemia complementation group D2 (FANCD2) in human tumors.
    Xie X; Zhao Y; Du F; Cai B; Fang Z; Liu Y; Sang Y; Ma C; Liu Z; Yu X; Zhang C; Jiang J; Gao Z; Liu Y; Lin X; Jing H; Zhong X; Cong L; Dai H; Sha D; Shao N; Feng H; Li L; Liu J; Shang L
    Genomics; 2024 Jan; 116(1):110762. PubMed ID: 38104669
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis.
    Wei W; Shi F; Xu Y; Jiao Y; Zhang Y; Ou Q; Wu X; Yang L; Lai J
    J Transl Med; 2023 Dec; 21(1):874. PubMed ID: 38041093
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mitochondria-related lncRNAs: predicting prognosis, tumor microenvironment and treatment response in lung adenocarcinoma.
    Zhou Q; Xiong J; Gao Y; Yi R; Xu Y; Chen Q; Wang L; Chen Y
    Funct Integr Genomics; 2023 Oct; 23(4):323. PubMed ID: 37864709
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of fatty acid-related subtypes, the establishment of a prognostic signature, and immune infiltration characteristics in lung adenocarcinoma.
    Wang Y; Huang X; Fan H; Xu Y; Qi Z; Zhang Y; Huang Y
    Aging (Albany NY); 2023 May; 15(10):4202-4235. PubMed ID: 37199651
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A subset of VEGFR-TKIs activates AMPK in LKB1-mutant lung cancer.
    Yang L; Zhang Q; Xiong Y; Dang Z; Xiao H; Chen Q; Dai X; Zhang L; Zhu J; Wang D; Li M
    Cancer Sci; 2023 Apr; 114(4):1651-1662. PubMed ID: 36459496
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High expression levels of FANCI correlate with worse prognosis and promote tumor growth of lung adenocarcinoma partly via suppression of M1 macrophages.
    Li W; Yu M; Zhang J; Huang J; Lin Z; Chen J; Jiang G; Lin X
    Gene; 2023 Jan; 851():147053. PubMed ID: 36395972
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Gene network Analysis Defines a Subgroup of Small Cell lung cancer patients With Short Survival.
    Cucchiara F; Petrini I; Passaro A; Attili I; Crucitta S; Pardini E; de Marinis F; Danesi R; Del Re M
    Clin Lung Cancer; 2022 Sep; 23(6):510-521. PubMed ID: 35739016
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of variations in the Fanconi anemia complementation group and prognosis in Non-small cell lung cancer patients with Platinum-based chemotherapy.
    Mo JL; Liu JS; Xiao Q; Hong WX; Yin JY; Chen J; Liu ZQ
    Gene; 2022 May; 825():146398. PubMed ID: 35306114
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sulforaphane downregulated fatty acid synthase and inhibited microtubule-mediated mitophagy leading to apoptosis.
    Yan Y; Zhou Y; Li J; Zheng Z; Hu Y; Li L; Wu W
    Cell Death Dis; 2021 Oct; 12(10):917. PubMed ID: 34620841
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy.
    Lyu Q; Zhu W; Wei T; Ding W; Cao M; Wang Q; Guo L; Luo P; Zhang J
    Cancer Med; 2021 Nov; 10(21):7863-7876. PubMed ID: 34564955
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway.
    Fan XZ; Chen YF; Zhang SB; He DH; Wei SF; Wang Q; Pan HF; Liu YQ
    Phytomedicine; 2021 Oct; 91():153689. PubMed ID: 34446320
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
    Quan J; Bode AM; Luo X
    Eur J Pharmacol; 2021 Oct; 909():174397. PubMed ID: 34332918
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Frondoside A Inhibits an MYC-Driven Medulloblastoma Model Derived from Human-Induced Pluripotent Stem Cells.
    Xue Y; Fu Y; Zhao F; Gui G; Li Y; Rivero-Hinojosa S; Liu G; Li Y; Xia S; Eberhart CG; Ying M
    Mol Cancer Ther; 2021 Jun; 20(6):1199-1209. PubMed ID: 33722850
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.
    Taghizadeh H; Zöchbauer-Müller S; Mader RM; Müllauer L; Klikovits T; Bachleitner-Hofmann T; Hoda MA; Prager GW
    Thorac Cancer; 2020 Jul; 11(7):1979-1988. PubMed ID: 32438515
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Preliminary Study on Detection of Circulating Tumor Cells in lung cancer by EGFR/Vimentin/Folic Acid Magnetic Sphere].
    Li G; Wang Y; Tan G; Liu Y; Xu Z; Feng H; Xing W; Xu Z
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):351-359. PubMed ID: 32336066
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells.
    Santana-Codina N; Marcé-Grau A; Muixí L; Nieva C; Marro M; Sebastián D; Muñoz JP; Zorzano A; Sierra A
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395819
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data.
    Xia Z; Ou-Yang W; Hu T; Du K
    Cancer Genet; 2019 Apr; 233-234():67-74. PubMed ID: 31109596
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib.
    Guan J; Fransson S; Siaw JT; Treis D; Van den Eynden J; Chand D; Umapathy G; Ruuth K; Svenberg P; Wessman S; Shamikh A; Jacobsson H; Gordon L; Stenman J; Svensson PJ; Hansson M; Larsson E; Martinsson T; Palmer RH; Kogner P; Hallberg B
    Cold Spring Harb Mol Case Stud; 2018 Aug; 4(4):. PubMed ID: 29907598
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting PRPK Function Blocks Colon cancer Metastasis.
    Zykova T; Zhu F; Wang L; Li H; Lim DY; Yao K; Roh E; Yoon SP; Kim HG; Bae KB; Wen W; Shin SH; Nadas J; Li Y; Ma W; Bode AM; Dong Z
    Mol Cancer Ther; 2018 May; 17(5):1101-1113. PubMed ID: 29483219
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
    Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R
    Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 2.